Zohreh Fasihi

Zohreh Fasihi

Auto-generated profile, based on publicly available information

Zohreh Fasihi

Food and Drug Control Laboratory, Hamadan University of Medical Sciences, Hamadan, Iran

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2021 in Journal of Obesity
Verified
Journal Article
Open access
PDF file
FFFarzin Firozian
Farzin Firozian
ANAmir Nili-Ahmadabadi
Amir Nili-Ahmadabadi
SMShirin Moradkhani
Shirin Moradkhani
MMMiad Moulaei
Miad Moulaei
ZFZohreh Fasihi
Zohreh Fasihi
DADavoud Ahmadimoghaddam
Davoud Ahmadimoghaddam
Background. Some anorexic agents are used to fraudulent augmentation herbal weight loss formulations. This study was designed to evaluate the potential existence of illicit substances in 63 herbal weight loss formulations collected from local apothecaries in Hamadan, Iran. Methods. The thin-layer chromatography method was applied for the primary screening of potential illicit substances in the samples. The positive samples were analyzed using an isocratic high-performance liquid chromatography method. Results. The results showed that 26.98 of the samples contained 17.76±6.02mg/cap of sibutramine. Daily therapeutic dose intake of sibutramine is in the range of 5 to 15mg daily. Conclusion. Since apothecaries have advised consumers to take at least two capsules a day, it seems that the blood concentration of sibutramine will likely rise beyond the therapeutic concentration and become toxic. Therefore, the usage of such products could pose serious risks to consumers health.